| 1 | the international peptide society | | | | | | | 2 | 0.51% |
| 2 | build towards regenerative health | | | | | | | 1 | 0.25% |
| 3 | worldclass education offered by | | | | | | | 1 | 0.25% |
| 4 | to worldclass education offered | | | | | | | 1 | 0.25% |
| 5 | education discounts exclusive discounts | | | | | | | 1 | 0.25% |
| 6 | benefits education discounts exclusive | | | | | | | 1 | 0.25% |
| 7 | memberonly benefits education discounts | | | | | | | 1 | 0.25% |
| 8 | more memberonly benefits education | | | | | | | 1 | 0.25% |
| 9 | read more memberonly benefits | | | | | | | 1 | 0.25% |
| 10 | and build towards regenerative | | | | | | | 1 | 0.25% |
| 11 | offered by tarsus medical | | | | | | | 1 | 0.25% |
| 12 | relationships and build towards | | | | | | | 1 | 0.25% |
| 13 | chemistry relationships and build | | | | | | | 1 | 0.25% |
| 14 | bodily chemistry relationships and | | | | | | | 1 | 0.25% |
| 15 | the potential to rewrite | | | | | | | 1 | 0.25% |
| 16 | has the potential to | | | | | | | 1 | 0.25% |
| 17 | peptides has the potential | | | | | | | 1 | 0.25% |
| 18 | of peptides has the | | | | | | | 1 | 0.25% |
| 19 | education offered by tarsus | | | | | | | 1 | 0.25% |
| 20 | by tarsus medical education | | | | | | | 1 | 0.25% |
| 21 | targeted use of peptides | | | | | | | 1 | 0.25% |
| 22 | a myriad of topics | | | | | | | 1 | 0.25% |
| 23 | by key industry thought | | | | | | | 1 | 0.25% |
| 24 | presented by key industry | | | | | | | 1 | 0.25% |
| 25 | therapy presented by key | | | | | | | 1 | 0.25% |
| 26 | and applications for peptide | | | | | | | 1 | 0.25% |
| 27 | topics and applications for | | | | | | | 1 | 0.25% |
| 28 | of topics and applications | | | | | | | 1 | 0.25% |
| 29 | myriad of topics and | | | | | | | 1 | 0.25% |
| 30 | covering a myriad of | | | | | | | 1 | 0.25% |
| 31 | tarsus medical education brands | | | | | | | 1 | 0.25% |
| 32 | webinars covering a myriad | | | | | | | 1 | 0.25% |
| 33 | learning opportunities valuable monthly | | | | | | | 1 | 0.25% |
| 34 | livderm learning opportunities valuable | | | | | | | 1 | 0.25% |
| 35 | and livderm learning opportunities | | | | | | | 1 | 0.25% |
| 36 | cmhc and livderm learning | | | | | | | 1 | 0.25% |
| 37 | a4m cmhc and livderm | | | | | | | 1 | 0.25% |
| 38 | including a4m cmhc and | | | | | | | 1 | 0.25% |
| 39 | use of peptides has | | | | | | | 1 | 0.25% |
| 40 | the targeted use of | | | | | | | 1 | 0.25% |